Blue Magoo
A berry-scented hybrid with disputed lineage, popular for its color and aroma more than any verified clinical effect.
Blue Magoo is a real, well-loved hybrid with a distinctive berry-grape smell and frequently purple flowers. Beyond that, almost everything you'll read about it — exact lineage, THC numbers, predictable 'effects' — is marketing or community lore. There are no clinical studies on Blue Magoo specifically. If you like the smell and a grower you trust produces it well, that's a fine reason to buy it. Just don't expect the strain name to predict how you'll feel.
Overview
Blue Magoo is a hybrid cannabis variety that circulated widely in the U.S. medical market starting in the late 2000s. It's known for a strong berry, grape, and floral aroma and a tendency to throw purple coloration in cooler finishing temperatures. The name is most commonly associated with breeder DJ Short, who has discussed Blue Magoo and related Blueberry-family crosses in interviews and his own writing [1][2].
Beyond aroma and appearance, there is no peer-reviewed literature specifically characterizing Blue Magoo's chemistry or effects No data. Reported numbers come from dispensary menus and aggregator sites, which are not standardized.
Chemistry: Cannabinoids and Terpenes
Public lab data for Blue Magoo is sparse and scattered across state testing programs and menu aggregators rather than peer-reviewed sources. Reported THC values typically fall in the mid-to-high teens, with negligible CBD — consistent with most modern drug-type cultivars [3] Weak / limited.
Terpene profile reports vary. Many samples lead with myrcene, sometimes with notable pinene or caryophyllene; some phenotypes show terpinolene-forward profiles. This variability is normal: research shows that the same strain name can produce very different chemotypes across growers and harvests [4] Strong evidence. In other words, two jars labeled 'Blue Magoo' may not be chemically similar.
The popular claim that myrcene above 0.5% guarantees a 'couch-lock' indica effect is folklore, not science No data. There is no published threshold like that in peer-reviewed pharmacology.
Reported Effects
Users commonly describe Blue Magoo as relaxing, mildly euphoric, and body-heavy, with reports of help for sleep, stress, or pain Anecdote. These are community impressions from sites like Leafly and grower forums, not clinical findings.
There are no controlled clinical trials of Blue Magoo No data. The broader cannabis literature supports that THC-dominant flower can acutely affect mood, appetite, pain perception, and sleep architecture, but those effects are driven by dose, route, set, setting, and individual biology — not by strain branding [5] Strong evidence. The widely repeated 'indica vs sativa predicts effects' framework is not supported by chemistry or pharmacology [6] Strong evidence.
If Blue Magoo reliably relaxes you, that's a real personal observation worth tracking — just don't assume the next batch with the same name will do the same thing.
Lineage (Disputed)
Blue Magoo's lineage is one of the genuinely murky areas of the strain's history.
The most commonly cited origin attributes Blue Magoo to DJ Short, the breeder behind the Blueberry family, with the cross usually described as Blueberry × William's Wonder or a Blueberry-line backcross [1][2] Disputed. Some sources instead describe it as a cross involving Aloha Blue Dream or other Blueberry × Northern Lights derivatives Disputed. A separate 'Blue Magoo BX' (backcross) line has also circulated, further muddying provenance.
Because cannabis genetics historically moved through informal seed exchanges with no registry, multiple 'Blue Magoo' lines almost certainly exist in circulation today. Genetic studies have repeatedly shown that strain names are unreliable indicators of actual genetic identity [7] Strong evidence. Treat any lineage chart you see online as a hypothesis, not a fact.
Cultivation Basics
Growers describe Blue Magoo as a moderately demanding plant — not a beginner's strain, but not exotic either Anecdote. Common community-reported notes:
- Flowering time: roughly 8–9 weeks indoors.
- Structure: medium height, branchy, responds well to topping and light training.
- Color: purple expression is encouraged by cooler night temperatures in late flower, a general anthocyanin response also seen in other Blueberry-line cultivars Weak / limited.
- Aroma in flower: pronounced berry and floral notes; can be loud, so carbon filtration is recommended for indoor grows.
- Sensitivity: like many Blueberry descendants, reports suggest some sensitivity to nutrient overload; growers often run lighter feed schedules.
There is no standardized, peer-reviewed agronomic data for Blue Magoo specifically No data. Yield, cannabinoid content, and terpene expression will depend heavily on the specific cut, environment, and grower.
Marketing vs. Reality
What's real about Blue Magoo:
- A distinct, recognizable berry/grape aroma in well-grown examples.
- A tendency toward purple coloration under the right conditions.
- A genuine connection to the Blueberry breeding lineage popularized by DJ Short.
What's marketing or folklore:
- Precise THC percentages on menus. Independent audits have repeatedly found that dispensary THC labels are often inflated relative to verified lab testing [8] Strong evidence.
- Claims that Blue Magoo is 'an indica' that will reliably sedate you. Indica/sativa labels don't map cleanly to chemistry or effects [6] Strong evidence.
- Specific medical claims (e.g., 'good for anxiety,' 'treats insomnia'). No strain-specific trials exist No data.
- A single 'true' lineage. Multiple Blue Magoo lines exist, and strain names are not genetic identifiers [7] Strong evidence.
If you enjoy Blue Magoo, enjoy it for what it actually is: a nice-smelling, often pretty hybrid with a real breeding pedigree and a lot of variability between batches.
Sources
- Reported Danko, D. (2011). 'DJ Short: The Blueberry Bandit.' High Times interview archive.
- Practitioner DJ Short. Breeder notes and interviews on Blueberry-family genetics, published via DJ Short Seeds.
- Reported Leafly strain database entry for Blue Magoo (aggregated user and lab-reported chemistry).
- Peer-reviewed Smith, C. J., Vergara, D., Keegan, B., & Jikomes, N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
- Peer-reviewed Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364.
- Peer-reviewed Piomelli, D., & Russo, E. B. (2016). The Cannabis sativa Versus Cannabis indica Debate: An Interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 1(1), 44–46.
- Peer-reviewed Schwabe, A. L., & McGlaughlin, M. E. (2019). Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry. Journal of Cannabis Research, 1, 3.
- Peer-reviewed Jikomes, N., & Zoorob, M. (2018). The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products. Scientific Reports, 8, 4519.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.
Related
- Blue Dream — California's most-sold sativa-dominant hybrid, famous for balanced effects, easy growing,...
- Myrcene — The most common monoterpene in cannabis, blamed and credited for a lot of things it probab...